Mineralys Therapeutics, Inc. SEC filings MLYS

Mineralys Therapeutics, Inc. has 408 filings in SEC EDGAR's recent list, going back to Jun 13, 2022. Its latest annual report, Form ARS, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations, officer or director change). The company's fiscal year ends on December 31.

Form Description Filed Period
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
10-Q Quarterly report Aug 11, 2026 Jun 30, 2026
10-Q Quarterly report May 6, 2026 Mar 31, 2026
10-Q Quarterly report Nov 10, 2025 Sep 30, 2025
10-Q Quarterly report Aug 12, 2025 Jun 30, 2025
10-Q Quarterly report May 12, 2025 Mar 31, 2025
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
10-Q Quarterly report Aug 13, 2024 Jun 30, 2024
10-Q Quarterly report May 9, 2024 Mar 31, 2024
10-Q Quarterly report Nov 7, 2023 Sep 30, 2023
10-Q Quarterly report Aug 7, 2023 Jun 30, 2023
10-Q Quarterly report May 15, 2023 Mar 31, 2023

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
MLYS (Nasdaq)
Fiscal year ends
December 31
Headquarters
Radnor, PA
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1933414

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.